ALLHAT Study Brings Calls For Comparative Trials, Greater Focus On Costs
The ALLHAT hypertension trial is bringing renewed calls for more comparative trials of pharmaceutical agents
The ALLHAT hypertension trial is bringing renewed calls for more comparative trials of pharmaceutical agents